Immunogenicity of the Q fever skin test.

[1]  L. Joosten,et al.  Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever. , 2013, The Journal of infection.

[2]  L. Joosten,et al.  Specific interferon γ detection for the diagnosis of previous Q fever. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Timen,et al.  Implementation of a Q fever vaccination program for high-risk patients in the Netherlands. , 2013, Vaccine.

[4]  Y. V. van Duynhoven,et al.  Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in The Netherlands: from acute to chronic infection. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  E. Bateman,et al.  Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. , 2009, American journal of respiratory and critical care medicine.

[6]  D. Waag,et al.  Low-Dose Priming before Vaccination with the Phase I Chloroform-Methanol Residue Vaccine against Q Fever Enhances Humoral and Cellular Immune Responses to Coxiella burnetii , 2008, Clinical and Vaccine Immunology.

[7]  B. Marmion.  Q fever: the long journey to control by vaccination , 2007, The Medical journal of Australia.

[8]  A. Banzhoff,et al.  Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. , 2000, Bulletin of the World Health Organization.

[9]  B. Marmion,et al.  Vaccine prophylaxis of Q fever: A follow‐up study of the efficacy of Q‐Vax (CSL) 1985‐1990 , 1994, The Medical journal of Australia.

[10]  M. Casey,et al.  SEROLOGIC AND SKIN-TEST RESPONSE AFTER Q FEVER VACCINATION BY THE INTRACUTANEOUS ROUTE. , 1964, Journal of immunology.